Robert Herman Shmerling, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Infectious | 9 | 2021 | 347 | 1.480 |
Why?
|
Antibodies, Antinuclear | 6 | 2022 | 340 | 1.400 |
Why?
|
Gout | 8 | 2022 | 620 | 1.310 |
Why?
|
Arthritis, Rheumatoid | 14 | 2017 | 3778 | 1.090 |
Why?
|
Antirheumatic Agents | 8 | 2017 | 1379 | 0.850 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2022 | 2160 | 0.840 |
Why?
|
Peptides, Cyclic | 3 | 2014 | 390 | 0.740 |
Why?
|
Diagnostic Tests, Routine | 2 | 2019 | 788 | 0.720 |
Why?
|
Gout Suppressants | 4 | 2018 | 176 | 0.640 |
Why?
|
Chondrocalcinosis | 2 | 2018 | 84 | 0.610 |
Why?
|
Prosthesis-Related Infections | 2 | 2021 | 497 | 0.600 |
Why?
|
Rheumatoid Factor | 7 | 2014 | 185 | 0.580 |
Why?
|
Arthritis | 4 | 2018 | 684 | 0.570 |
Why?
|
False Positive Reactions | 1 | 2019 | 959 | 0.540 |
Why?
|
Curettage | 1 | 2016 | 74 | 0.520 |
Why?
|
Synovial Fluid | 5 | 2021 | 391 | 0.490 |
Why?
|
Fibromyalgia | 3 | 2010 | 407 | 0.480 |
Why?
|
Rheumatology | 4 | 2017 | 617 | 0.480 |
Why?
|
Independent Living | 5 | 2019 | 584 | 0.430 |
Why?
|
Debridement | 1 | 2016 | 494 | 0.420 |
Why?
|
Arthritis, Gouty | 1 | 2012 | 28 | 0.410 |
Why?
|
Rheumatic Diseases | 5 | 2005 | 659 | 0.400 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2013 | 347 | 0.390 |
Why?
|
Laboratories | 1 | 2014 | 463 | 0.360 |
Why?
|
Common Cold | 1 | 2011 | 63 | 0.360 |
Why?
|
Critical Pathways | 1 | 2014 | 476 | 0.360 |
Why?
|
Eructation | 1 | 2010 | 6 | 0.350 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1417 | 0.350 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1389 | 0.350 |
Why?
|
Blood Sedimentation | 4 | 2014 | 235 | 0.340 |
Why?
|
Giant Cell Arteritis | 2 | 2006 | 307 | 0.340 |
Why?
|
Autoimmune Diseases | 1 | 2022 | 2255 | 0.340 |
Why?
|
Hyperpigmentation | 1 | 2011 | 116 | 0.330 |
Why?
|
Osteoarthritis | 5 | 2011 | 1072 | 0.320 |
Why?
|
Clinical Laboratory Techniques | 1 | 2014 | 746 | 0.320 |
Why?
|
Mucus | 1 | 2011 | 346 | 0.320 |
Why?
|
Eyelids | 1 | 2011 | 278 | 0.310 |
Why?
|
Xanthomatosis, Cerebrotendinous | 1 | 2008 | 9 | 0.310 |
Why?
|
Nasal Mucosa | 1 | 2011 | 416 | 0.290 |
Why?
|
Joints | 3 | 2016 | 324 | 0.290 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 2 | 2002 | 297 | 0.290 |
Why?
|
Cold Temperature | 1 | 2011 | 793 | 0.280 |
Why?
|
Methotrexate | 2 | 2014 | 1718 | 0.280 |
Why?
|
Glucocorticoids | 3 | 2015 | 2163 | 0.280 |
Why?
|
Prednisone | 2 | 2018 | 1566 | 0.280 |
Why?
|
Edema | 1 | 2011 | 764 | 0.280 |
Why?
|
Tai Ji | 1 | 2010 | 291 | 0.270 |
Why?
|
Eye Diseases | 1 | 2011 | 660 | 0.250 |
Why?
|
Uric Acid | 4 | 2022 | 805 | 0.240 |
Why?
|
Disability Evaluation | 3 | 2019 | 1829 | 0.230 |
Why?
|
Evidence-Based Medicine | 3 | 2015 | 3700 | 0.230 |
Why?
|
Autoantibodies | 2 | 2022 | 2114 | 0.230 |
Why?
|
Complementary Therapies | 1 | 2008 | 487 | 0.220 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2004 | 217 | 0.210 |
Why?
|
Pain Measurement | 7 | 2019 | 3584 | 0.210 |
Why?
|
Postural Balance | 5 | 2015 | 638 | 0.210 |
Why?
|
Glucosamine | 1 | 2002 | 128 | 0.200 |
Why?
|
Humans | 76 | 2022 | 767040 | 0.200 |
Why?
|
Chondroitin Sulfates | 1 | 2002 | 174 | 0.200 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9245 | 0.200 |
Why?
|
Transaminases | 1 | 2003 | 198 | 0.200 |
Why?
|
Staphylococcal Infections | 3 | 2021 | 1396 | 0.200 |
Why?
|
Counseling | 1 | 2009 | 1553 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2011 | 4054 | 0.190 |
Why?
|
S-Adenosylmethionine | 1 | 2002 | 219 | 0.190 |
Why?
|
Creatine Kinase | 1 | 2003 | 683 | 0.180 |
Why?
|
Exercise Therapy | 1 | 2008 | 939 | 0.180 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8048 | 0.170 |
Why?
|
Immunologic Tests | 1 | 2021 | 101 | 0.170 |
Why?
|
Breast Implants | 1 | 2003 | 414 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2006 | 3249 | 0.160 |
Why?
|
Melanoma | 1 | 2018 | 5702 | 0.160 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5859 | 0.150 |
Why?
|
Vasculitis | 1 | 2002 | 526 | 0.150 |
Why?
|
Mobility Limitation | 3 | 2019 | 409 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2021 | 408 | 0.140 |
Why?
|
Cognition | 2 | 2014 | 7059 | 0.140 |
Why?
|
Serologic Tests | 2 | 2014 | 382 | 0.140 |
Why?
|
Pain | 4 | 2016 | 5101 | 0.140 |
Why?
|
Bursitis | 1 | 2017 | 85 | 0.130 |
Why?
|
Biological Products | 2 | 2015 | 948 | 0.130 |
Why?
|
Retrospective Studies | 16 | 2021 | 81659 | 0.130 |
Why?
|
Colchicine | 2 | 2018 | 256 | 0.130 |
Why?
|
Hypertension | 2 | 2020 | 8615 | 0.130 |
Why?
|
Anticholesteremic Agents | 1 | 2003 | 969 | 0.130 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1996 | 425 | 0.130 |
Why?
|
Pregnancy Complications | 1 | 2009 | 2971 | 0.120 |
Why?
|
Fingers | 2 | 1988 | 508 | 0.120 |
Why?
|
Musculoskeletal System | 2 | 2009 | 188 | 0.120 |
Why?
|
Pain Perception | 1 | 2016 | 198 | 0.120 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 705 | 0.120 |
Why?
|
Endocarditis, Bacterial | 1 | 2019 | 436 | 0.120 |
Why?
|
Middle Aged | 28 | 2022 | 223233 | 0.120 |
Why?
|
Male | 39 | 2022 | 364203 | 0.110 |
Why?
|
Arthralgia | 3 | 2018 | 459 | 0.110 |
Why?
|
Sensitivity and Specificity | 7 | 2013 | 14672 | 0.110 |
Why?
|
Aged | 33 | 2022 | 171319 | 0.110 |
Why?
|
Aged, 80 and over | 19 | 2020 | 59548 | 0.110 |
Why?
|
Geriatric Assessment | 2 | 2019 | 1422 | 0.110 |
Why?
|
Anti-Bacterial Agents | 3 | 2021 | 7469 | 0.110 |
Why?
|
Predictive Value of Tests | 7 | 2014 | 15424 | 0.100 |
Why?
|
Geriatrics | 1 | 1996 | 394 | 0.100 |
Why?
|
Qi | 1 | 2011 | 15 | 0.100 |
Why?
|
Diagnostic Errors | 1 | 2019 | 1278 | 0.100 |
Why?
|
Toes | 1 | 2012 | 209 | 0.100 |
Why?
|
Female | 37 | 2021 | 396660 | 0.100 |
Why?
|
Tendons | 1 | 2016 | 556 | 0.090 |
Why?
|
Boston | 7 | 2019 | 9360 | 0.090 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12986 | 0.090 |
Why?
|
Patient Education as Topic | 2 | 2011 | 2337 | 0.090 |
Why?
|
Lactose Intolerance | 1 | 2010 | 28 | 0.090 |
Why?
|
Reoperation | 1 | 2021 | 4325 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2030 | 0.090 |
Why?
|
Indium | 1 | 1990 | 47 | 0.090 |
Why?
|
Control Groups | 1 | 2010 | 107 | 0.090 |
Why?
|
Indium Radioisotopes | 1 | 1990 | 114 | 0.090 |
Why?
|
Analgesics | 1 | 2017 | 1071 | 0.080 |
Why?
|
Hyperuricemia | 1 | 2012 | 221 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2018 | 2270 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3611 | 0.080 |
Why?
|
Activities of Daily Living | 3 | 2019 | 2429 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3851 | 0.080 |
Why?
|
Disabled Persons | 2 | 2018 | 1209 | 0.080 |
Why?
|
Chenodeoxycholic Acid | 1 | 2008 | 34 | 0.080 |
Why?
|
Risk Assessment | 3 | 2019 | 24299 | 0.080 |
Why?
|
Hydrotherapy | 1 | 2008 | 6 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 2 | 2018 | 1883 | 0.080 |
Why?
|
Bacteria | 1 | 2019 | 2212 | 0.070 |
Why?
|
Antilymphocyte Serum | 1 | 1989 | 490 | 0.070 |
Why?
|
Cathartics | 1 | 2009 | 129 | 0.070 |
Why?
|
Range of Motion, Articular | 1 | 2014 | 1597 | 0.070 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15925 | 0.070 |
Why?
|
Accidental Falls | 2 | 2018 | 1079 | 0.070 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6310 | 0.070 |
Why?
|
Orthotic Devices | 1 | 2008 | 131 | 0.070 |
Why?
|
Sepsis | 2 | 2020 | 2605 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 812 | 0.070 |
Why?
|
Leptin | 1 | 2015 | 1599 | 0.070 |
Why?
|
Delayed-Action Preparations | 1 | 2010 | 965 | 0.070 |
Why?
|
Joint Diseases | 1 | 1990 | 461 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6489 | 0.070 |
Why?
|
Organ Specificity | 1 | 2011 | 1966 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7435 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39317 | 0.060 |
Why?
|
Seasons | 1 | 2011 | 1523 | 0.060 |
Why?
|
Prevalence | 6 | 2019 | 15851 | 0.060 |
Why?
|
Face | 1 | 2011 | 1029 | 0.060 |
Why?
|
Risk Factors | 10 | 2020 | 74886 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1804 | 0.060 |
Why?
|
Irritable Bowel Syndrome | 1 | 2010 | 454 | 0.060 |
Why?
|
Physicians | 1 | 2022 | 4593 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2015 | 1251 | 0.060 |
Why?
|
Brain | 1 | 2011 | 27163 | 0.060 |
Why?
|
Physical Therapy Modalities | 1 | 2008 | 533 | 0.060 |
Why?
|
Opportunistic Infections | 1 | 2007 | 375 | 0.060 |
Why?
|
Medical Records | 2 | 2002 | 1409 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4627 | 0.060 |
Why?
|
Abdomen | 1 | 2010 | 1138 | 0.060 |
Why?
|
Acetaminophen | 2 | 2018 | 549 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2009 | 1188 | 0.050 |
Why?
|
Resuscitation | 1 | 1988 | 681 | 0.050 |
Why?
|
Rhinitis | 1 | 2011 | 753 | 0.050 |
Why?
|
Neurosecretory Systems | 1 | 2004 | 223 | 0.050 |
Why?
|
Diet | 1 | 2021 | 8089 | 0.050 |
Why?
|
Polyethylene Glycols | 1 | 2009 | 1188 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11217 | 0.050 |
Why?
|
Silicones | 1 | 2003 | 228 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2010 | 834 | 0.050 |
Why?
|
Acupuncture | 1 | 2002 | 90 | 0.050 |
Why?
|
Biopsy | 2 | 2006 | 6777 | 0.050 |
Why?
|
Plants, Medicinal | 1 | 2002 | 167 | 0.050 |
Why?
|
Adult | 12 | 2022 | 223317 | 0.050 |
Why?
|
Cohort Studies | 7 | 2018 | 41718 | 0.050 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2011 | 1107 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4855 | 0.050 |
Why?
|
Aspartate Aminotransferases | 1 | 2003 | 415 | 0.050 |
Why?
|
Obesity | 2 | 2015 | 13085 | 0.050 |
Why?
|
Quality of Life | 3 | 2018 | 13485 | 0.050 |
Why?
|
Hospitalization | 2 | 2020 | 10815 | 0.050 |
Why?
|
Physical Examination | 2 | 2009 | 1265 | 0.040 |
Why?
|
Chlorthalidone | 1 | 2020 | 21 | 0.040 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2007 | 836 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2003 | 609 | 0.040 |
Why?
|
Lisinopril | 1 | 2020 | 60 | 0.040 |
Why?
|
Amlodipine | 1 | 2020 | 84 | 0.040 |
Why?
|
Atenolol | 1 | 2020 | 99 | 0.040 |
Why?
|
Attitude to Health | 1 | 1988 | 2023 | 0.040 |
Why?
|
Motor Activity | 1 | 2009 | 2713 | 0.040 |
Why?
|
Ascorbic Acid | 1 | 2022 | 658 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2020 | 11513 | 0.040 |
Why?
|
Safety | 1 | 2003 | 1157 | 0.040 |
Why?
|
Incidence | 2 | 2019 | 21526 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2003 | 552 | 0.040 |
Why?
|
Pregnancy Outcome | 1 | 2009 | 2972 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2020 | 65295 | 0.040 |
Why?
|
Prognosis | 3 | 2017 | 29963 | 0.040 |
Why?
|
Vitamin E | 1 | 2022 | 872 | 0.040 |
Why?
|
Medical History Taking | 1 | 2002 | 779 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8729 | 0.040 |
Why?
|
Knee | 1 | 2019 | 277 | 0.040 |
Why?
|
Olecranon Process | 1 | 2017 | 16 | 0.040 |
Why?
|
Central Nervous System | 1 | 2004 | 1345 | 0.040 |
Why?
|
Medical Records Systems, Computerized | 1 | 2003 | 1196 | 0.030 |
Why?
|
Dementia | 1 | 2011 | 2741 | 0.030 |
Why?
|
Israel | 1 | 2018 | 726 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 1999 | 412 | 0.030 |
Why?
|
Weight Loss | 1 | 2008 | 2716 | 0.030 |
Why?
|
United States | 5 | 2021 | 72971 | 0.030 |
Why?
|
ROC Curve | 2 | 1996 | 3618 | 0.030 |
Why?
|
Hospitals, University | 1 | 2017 | 570 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 370 | 0.030 |
Why?
|
Patella | 1 | 2017 | 317 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2003 | 1672 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3804 | 0.030 |
Why?
|
Societies, Medical | 2 | 2015 | 3964 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 1988 | 3266 | 0.030 |
Why?
|
Suburban Population | 1 | 2014 | 54 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2021 | 2105 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1999 | 700 | 0.030 |
Why?
|
Diphtheria Toxin | 1 | 1995 | 253 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2018 | 282 | 0.030 |
Why?
|
Polypharmacy | 1 | 2017 | 307 | 0.030 |
Why?
|
Urinary Incontinence | 1 | 2018 | 490 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1639 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4210 | 0.030 |
Why?
|
Echocardiography, Transesophageal | 1 | 2019 | 1096 | 0.030 |
Why?
|
Shock, Septic | 1 | 2019 | 772 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 1989 | 10254 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2017 | 2850 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1996 | 1156 | 0.020 |
Why?
|
Comorbidity | 3 | 2011 | 10582 | 0.020 |
Why?
|
Age Factors | 2 | 2020 | 18401 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10393 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2022 | 12451 | 0.020 |
Why?
|
Pelvic Bones | 1 | 1992 | 274 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2022 | 3446 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2009 | 26396 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2017 | 1429 | 0.020 |
Why?
|
Gait | 1 | 2014 | 823 | 0.020 |
Why?
|
Interleukin-2 | 1 | 1995 | 1894 | 0.020 |
Why?
|
Spinal Stenosis | 1 | 2011 | 259 | 0.020 |
Why?
|
General Surgery | 1 | 2020 | 1720 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1990 | 1623 | 0.020 |
Why?
|
Pregnancy | 1 | 2009 | 30238 | 0.020 |
Why?
|
Arterial Occlusive Diseases | 1 | 2011 | 743 | 0.020 |
Why?
|
Odds Ratio | 2 | 2009 | 9660 | 0.020 |
Why?
|
Liver | 1 | 2003 | 7578 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2714 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 59980 | 0.020 |
Why?
|
Critical Illness | 1 | 2020 | 2753 | 0.020 |
Why?
|
Synovial Membrane | 1 | 1990 | 536 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3467 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 5042 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2044 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1990 | 1606 | 0.020 |
Why?
|
Primary Health Care | 1 | 2003 | 4746 | 0.020 |
Why?
|
Sarcoidosis | 1 | 1992 | 535 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8504 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1990 | 1987 | 0.020 |
Why?
|
Consensus | 1 | 2015 | 3207 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 14098 | 0.020 |
Why?
|
Chronic Disease | 2 | 2011 | 9362 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8535 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2011 | 716 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6331 | 0.020 |
Why?
|
Ankle Joint | 1 | 2009 | 452 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8890 | 0.010 |
Why?
|
Blood Pressure | 1 | 2020 | 8531 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 20169 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2920 | 0.010 |
Why?
|
Patient Selection | 1 | 2015 | 4256 | 0.010 |
Why?
|
Patient Readmission | 1 | 2017 | 3283 | 0.010 |
Why?
|
Research Design | 1 | 1999 | 6210 | 0.010 |
Why?
|
Disclosure | 1 | 1988 | 755 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 1992 | 1885 | 0.010 |
Why?
|
Walking | 1 | 2009 | 1201 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2007 | 640 | 0.010 |
Why?
|
Informed Consent | 1 | 1988 | 1010 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4881 | 0.010 |
Why?
|
Health Surveys | 1 | 2011 | 4056 | 0.010 |
Why?
|
Radiography | 2 | 1992 | 6975 | 0.010 |
Why?
|
Lung Diseases | 1 | 2011 | 1942 | 0.010 |
Why?
|
Decision Making | 2 | 1999 | 3951 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3837 | 0.010 |
Why?
|
Colonoscopy | 1 | 2009 | 1409 | 0.010 |
Why?
|
Knee Joint | 1 | 2009 | 1683 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2009 | 2116 | 0.010 |
Why?
|
Depression | 1 | 2018 | 8234 | 0.010 |
Why?
|
Case-Control Studies | 1 | 1996 | 22254 | 0.010 |
Why?
|
Heart Diseases | 1 | 2011 | 2817 | 0.010 |
Why?
|
Professional Practice | 1 | 1999 | 314 | 0.010 |
Why?
|
Information Systems | 1 | 1999 | 400 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13048 | 0.010 |
Why?
|
Complement System Proteins | 1 | 1999 | 738 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2007 | 4349 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 1999 | 602 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5886 | 0.010 |
Why?
|
Osteosclerosis | 1 | 1992 | 41 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2011 | 26325 | 0.010 |
Why?
|
Bone Diseases | 1 | 1992 | 416 | 0.000 |
Why?
|
Lymphocytes | 1 | 1995 | 2605 | 0.000 |
Why?
|
Antibodies | 1 | 1995 | 2419 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1995 | 3738 | 0.000 |
Why?
|
Spinal Diseases | 1 | 1992 | 561 | 0.000 |
Why?
|
Prospective Studies | 1 | 1990 | 54886 | 0.000 |
Why?
|
Antigens, CD | 1 | 1995 | 4032 | 0.000 |
Why?
|
Pilot Projects | 1 | 1995 | 8732 | 0.000 |
Why?
|
Adolescent | 1 | 1995 | 89046 | 0.000 |
Why?
|